These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 38073096)

  • 41. The role of gut microbiota in liver regeneration.
    Xu Z; Jiang N; Xiao Y; Yuan K; Wang Z
    Front Immunol; 2022; 13():1003376. PubMed ID: 36389782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
    Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
    Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
    Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
    Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
    Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
    El Hage R; Al-Arawe N; Hinterseher I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiota and Environment in Coronary Artery Disease.
    Piccioni A; de Cunzo T; Valletta F; Covino M; Rinninella E; Raoul P; Zanza C; Mele MC; Franceschi F
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
    He M; Tan CP; Xu YJ; Liu Y
    Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease.
    Zhang Z; Lv T; Wang X; Wu M; Zhang R; Yang X; Fu Y; Liu Z
    Biomed Pharmacother; 2024 May; 174():116567. PubMed ID: 38583340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder.
    Fu K; Ma C; Wang C; Zhou H; Gong L; Zhang Y; Li Y
    Biomed Pharmacother; 2022 Jul; 151():113185. PubMed ID: 35623173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet-gut microbiota interactions on cardiovascular disease.
    Zhang X; Gérard P
    Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats.
    Hu Y; Pan Z; Huang Z; Li Y; Han N; Zhuang X; Peng H; Gao Q; Wang Q; Yang Lee BJ; Zhang H; Yang R; Bi Y; Xu ZZ
    Microbiol Spectr; 2022 Feb; 10(1):e0105321. PubMed ID: 35138162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.
    Zhang W; Dong XY; Huang R
    Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease.
    Rodríguez-Morató J; Matthan NR
    Curr Atheroscler Rep; 2020 Jul; 22(9):47. PubMed ID: 32681421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
    Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
    Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.